ANCN News and Press, Chemomab Therapeutics From 05/11/20

CAMBRIDGE, Mass., May 11, 2020 (GLOBE NEWSWIRE) -- Anchiano Therapeutics Ltd. (Nasdaq: ANCN) (“Anchiano”), a preclinical biopharmaceutical company dedicated to the discovery and development of new cancer therapies designed to target the products of mutated genes that are drive...

CAMBRIDGE, Mass., May 05, 2020 (GLOBE NEWSWIRE) -- Anchiano Therapeutics Ltd. (Nasdaq: ANCN) (the “Company”) today announced it has appointed Mr. Steve DiPalma as its Chief Financial Officer. Mr. DiPalma has served as a Senior Financial Advisor to Anchiano by agreement with Da...

CAMBRIDGE, Mass., April 17, 2020 (GLOBE NEWSWIRE) -- Anchiano Therapeutics Ltd. (Nasdaq: ANCN) (the “Company”) today announced it has elected to hold its 2020 Annual General Meeting of Shareholders (the “Annual Meeting”) as a virtual meeting due to the ongoing pu...

Anchiano Therapeutics (NASDAQ: ANCN ): FY GAAP EPS of -$0.79 misses by $0.31 . More news on: Anchiano Therapeutics Ltd, Earnings news and commentary, Healthcare stocks news, , Read more ...

CAMBRIDGE, Mass., March 18, 2020 (GLOBE NEWSWIRE) -- Anchiano Therapeutics Ltd. (Nasdaq: ANCN) (“Anchiano”), a biopharmaceutical company focused on discovery and development of novel therapies to treat cancer, today reported financial results for the year ended December 3...

CAMBRIDGE, Mass., Jan. 17, 2020 (GLOBE NEWSWIRE) -- Anchiano Therapeutics Ltd. (Nasdaq: ANCN) (the “Company”) announced today that its board of directors approved the record date for the Company’s 2020 Annual General Meeting of Shareholders (the “Annual Meeting&#...

Gainers:  Karuna Therapeutics (NASDAQ: KRTX ) +282% More news on: Karuna Therapeutics, Inc., Hermitage Offshore Services Ltd., Eltek Ltd., Stocks on the move, Read more ...

Acasti Pharma (NASDAQ: ACST ) resume with Buy rating and $8 (292% upside) price target at B. Riley FBR. Shares up  5%  premarket. More news on: Acasti Pharma Inc., Champions Oncology, Inc., DexCom, Inc., Healthcare stocks news, Stocks on the move, , Read more ...

Gainers:  Akerna (NASDAQ: KERN ) +47% . More news on: Akerna Corp., Mmtec, Inc., Melinta Therapeutics, Inc., Stocks on the move, Read more ...

Anchiano Therapeutics (NASDAQ: ANCN ): Q3 GAAP EPS of -$0.43 misses by $0.25 . cash and cash equivalents of $23.2M. Press Release More news on: Anchiano Therapeutics Ltd, Earnings news and commentary, Healthcare stocks news, ,